Business Description
Lixte Biotechnology Holdings Inc
NAICS : 325412
SIC : 2834
Share Class Description:
LIXTW: Warrants (01/01/2025)Total Employee Number:
3Description
Nomad Power Solutions Inc is a pioneering mobile, utility-grade truck-transportable battery energy storage system. The company's first-to-market products provide one megawatt of instantaneous power to an electrical grid or facility, bypassing months of construction typically required for traditional fixed installations. Its patented platforms, which are deployed on semi-trailers, serve emerging AI-driven applications, along with utilities, industrial operators, government agencies, and critical infrastructure providers through equipment sales, rentals and Energy-as-a-Service offerings. The group's products are Traveler, Voyager Eagle, Voyager Falcon, Voyager Hawk, and Compare Products. Its applications are Utilities, Peak Shaving, EV Charging, and Mining.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 11.5 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.13 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 32.3 | |||||
3-Year EPS without NRI Growth Rate | 35.4 | |||||
3-Year FCF Growth Rate | 39.9 | |||||
3-Year Book Growth Rate | -3.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 12.87 | |||||
Quick Ratio | 12.87 | |||||
Cash Ratio | 8.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -74.1 | |||||
Shareholder Yield % | -36.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -91.7 | |||||
ROA % | -75.92 | |||||
ROIC % | -128.08 | |||||
3-Year ROIIC % | 14.51 | |||||
ROC (Joel Greenblatt) % | -118.7 | |||||
ROCE % | -85.48 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 2.93 | |||||
EV-to-EBIT | -6.73 | |||||
EV-to-EBITDA | -6.73 | |||||
EV-to-FCF | -10.86 | |||||
Earnings Yield (Greenblatt) % | -14.86 | |||||
FCF Yield % | -7.83 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LIXTW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lixte Biotechnology Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0 - 1 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lixte Biotechnology Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lixte Biotechnology Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-08 23:30 | In 92 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 64 days | ||
| SPECIAL MEETING OF STOCKHOLDERS | 2026-09-04 13:00 | -- | ||
| Second quarter earnings results for 2026 | 2026-08-14 | -- | ||
| First quarter earnings results for 2026 | 2026-05-14 | -- | ||
| Annual report for 2025 | 2026-03-31 | -- | ||
| DealFlow Discovery Conference | 2026-01-28 | -- | ||
| General meeting for 2025 | 2025-12-08 23:30 | -- | ||
| Third quarter earnings results for 2025 | 2025-11-12 | -- | ||
| Guidance call for 2025 | 2025-11-03 16:00 | -- |
Show
Entries
Lixte Biotechnology Holdings Inc Frequently Asked Questions
What is Lixte Biotechnology Holdings Inc(LIXTW)'s stock price today?
The current price of LIXTW is $0.02. The 52 week high of LIXTW is $1.00 and 52 week low is $0.00.
When is next earnings date of Lixte Biotechnology Holdings Inc(LIXTW)?
The next earnings date of Lixte Biotechnology Holdings Inc(LIXTW) is 2026-11-12 Est..
Does Lixte Biotechnology Holdings Inc(LIXTW) pay dividends? If so, how much?
Lixte Biotechnology Holdings Inc(LIXTW) does not pay dividend.
Press Release
Articles on Lixte Biotechnology Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers